Collectively, these results underscore the impact of MYH11+αSMA+ CAFs on fostering an immunosuppressive TME, marked by increased Treg infiltration, in mTLS-positive NSCLC. The gene discussed is ACTA1; the disease is non-small cell lung carcinoma.